Notice of Meeting, 5093-5094 [2010-1902]
Download as PDF
<![CDATA[
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices
Name of Committee: National Cancer
Institute Special Emphasis Panel, Innovative
Technologies Development.
Date: March 10–11, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey E. DeClue, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8059,
Bethesda, MD 20892–8329, 301–496–7904,
decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, EDRN
Biomarker Development Labs (U01).
Date: March 10–11, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Sherwood Githens, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd. Room 8146, Bethesda, MD
20892, 301–435–1822,
githenss@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Anticancer Agents.
Date: March 24–26, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, NIH National Cancer Institute,
6116 Executive Boulevard, Room 7149,
Bethesda, MD 20892–8329, 301–594–1286,
peguesj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Nanotechnology Platform Partnerships.
Date: March 31–April 1, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Savvas C Makrides, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm 8053, Bethesda,
MD 20892, 301–496–7421,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Small
Grants Program for Cancer Epidemiology.
Date: April 15–16, 2010.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
18:35 Jan 29, 2010
Jkt 220001
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7149,
Bethesda, MD 20892–8329, 301–594–1286,
peguesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
5093
Review, Group Neurological Sciences and
Disorders A.
Date: March 3, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Argonaut Hotel, 495 Jefferson Street,
San Francisco, CA 94109.
Contact Person: Richard D. Crosland, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892–9529, 301–496–9223.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
[FR Doc. 2010–2030 Filed 1–29–10; 8:45 am]
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2010–1932 Filed 1–29–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders B.
Date: February 25–26, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: US Grant Hotel, 326 Broadway, San
Diego, CA 92101.
Contact Person: Ernest W Lyons, PhD,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–4056.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as-needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularly
scheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b (c)(6). Grant
applications for the ARRA: Limited
Competition ‘‘Electronic Data Methods’’
(U13) applications are to be reviewed
and discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
E:\FR\FM\01FEN1.SGM
01FEN1
5094
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices
disclosure under the above-cited
statutes.
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: ARRA: Limited
Competition ‘‘Electronic Data Methods’’
(U13).
Date: February 26, 2010 (Open on February
26 from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting).
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Forest Glen Conference Room, Bethesda,
Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
SEP Meeting on: Transforming Primary
Care (Ri 8).
Date: March 9–10, 2010 (Open on March 9
from 8:30 a.m. to 8:45 a.m. and closed for the
remainder of the meeting).
Place: Doubletree Hotel & Executive
Meeting Center, 8120 Wisconsin Avenue,
Conference Room TBD, Bethesda, Maryland
20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Dated: January 21, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–1902 Filed 1–29–10; 8:45 am]
Dated: January 25, 2010.
Carol M. Clancy,
Director.
[FR Doc. 2010–1900 Filed 1–29–10; 8:45 am]
BILLING CODE 4160–90–M
Agenda items for this meeting are
subject to change as priorities dictate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Centers for Disease Control and
Prevention
Notice of Meeting
jlentini on DSKJ8SOYB1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee on Immunization
Practices (ACIP)
VerDate Nov<24>2008
18:35 Jan 29, 2010
Jkt 220001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates
8 a.m.–6 p.m., February 24, 2010.
8 a.m.–3 p.m., February 25, 2010.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters To Be Discussed: The agenda will
include discussions on; Human
Papillomavirus (HPV) Vaccines; 13–Valent
Pneumococcal Conjugate Vaccine; Influenza
Vaccines; Rotavirus Vaccines; Vaccine
Supply Update; Meningococcal Vaccines;
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Dated: January 22, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–2043 Filed 1–29–10; 8:45 am]
BILLING CODE 4160–18–P
BILLING CODE 4160–90–M
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Transforming
Primary Care (Ri 8) applications are to
be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
Evidence Based Recommendations; Hepatitis
B vaccination for diabetics.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., Mailstop E–05, Atlanta, Georgia
30333, telephone (404)639–8836, fax
(404)639–8905.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Privacy Act of 1974; Report of an
Altered System of Records
AGENCY: Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of an Altered System of
Records (SOR).
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
the Health Resources and Services
Administration (HRSA) is publishing
notice of a proposal to alter the system
of records for the Health Education
Assistance On-Line Processing System
(HOPS), 09–15–0044.
The purposes of these alterations are
to update the location of this system and
the system manager, to modify routine
use number 6, correct typographical
errors, and to add routine use number
17 related to notification of breaches in
security or confidentiality of records
maintained in the system. In addition,
the section for Policies and Practices for
Storing, Retrieving, Accessing,
Retaining and Disposing of Records in
the System was updated. The ‘‘Authority
for Maintenance of System’’ provision
has been modified to reference Section
702 of the Public Health Service Act [42
U.S.C. Section 292a], as amended, and
to add the Debt Collection Improvement
Act (31 U.S.C. Sections 3701 and 3711–
3720E). Lastly, the ‘‘Disclosure to
Consumer Reporting Agencies’’
provision was modified to reference the
definition of a ‘‘consumer reporting
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Pages 5093-5094]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1902]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as-needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b
(c)(6). Grant applications for the ARRA: Limited Competition
``Electronic Data Methods'' (U13) applications are to be reviewed and
discussed at this meeting. These discussions are likely to reveal
personal information concerning individuals associated with the
applications. This information is exempt from mandatory
[[Page 5094]]
disclosure under the above-cited statutes.
SEP Meeting on: ARRA: Limited Competition ``Electronic Data
Methods'' (U13).
Date: February 26, 2010 (Open on February 26 from 8 a.m. to 8:15
a.m. and closed for the remainder of the meeting).
Place: Marriott Bethesda North Hotel & Conference Center, 5701
Marinelli Road, Forest Glen Conference Room, Bethesda, Maryland
20852.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for this meeting are subject to change as
priorities dictate.
Dated: January 21, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-1902 Filed 1-29-10; 8:45 am]
BILLING CODE 4160-90-M
